EndoCRIB

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameEndoCRIB
Drug Alias Nameartificial pancreas (Neocrin)islet cells (StemCells)neocell-EPOneocell-NPKneocell-PTH +[11] 
ClassificationCell and gene therapy > Cell therapyBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionInsulin modulators
TargetsUpdating
Therapy Area/IndicationsDiabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMicrobot Medical Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNeocrinMicrobot Medical Inc
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus

Other Information

ATC CodeN/A
Related LinksN/A